Decoding mitochondrial selective autophagy in synaptic homeostasis during ageing

SynaptoMitophagy aims to uncover the molecular mechanisms of age-related synaptic impairment through in vivo monitoring of mitochondrial maintenance and turnover using advanced technologies in C. elegans and mammalian neurons.

Subsidie
€ 1.500.000
2023

Projectdetails

Introduction

Age-dependent accumulation of damaged mitochondria and synaptic loss represent early pathological hallmarks of brain ageing leading to neuronal death. Mitochondria-selective autophagy (mitophagy) is triggered to eliminate defective organelles promoting cellular and organismal survival. Mitophagy declines with age, while its induction extends lifespan and confers neuroprotection across diverse species. Although the pivotal role of mitophagy in neuronal physiology is steadily emerging, its contribution to synaptic homeostasis remains elusive.

Project Overview

Building on our previous pioneering studies, SynaptoMitophagy aims to reveal the molecular underpinnings of age-dependent synaptic impairment, focusing on mitochondrial maintenance and turnover.

We will combine the nematode Caenorhabditis elegans, which offers a well-defined nervous system, with cutting-edge technologies, such as super resolution imaging, microfluidics, and optogenetics, to manipulate spatiotemporally mitochondrial damage and monitor synaptic mitophagy at nanoscale resolution, in vivo. Mammalian neurons will be used to address the functional conservation of synaptic mitophagy components.

Objectives

The objectives are four-fold:

  1. Establish mitophagy reporters for in vivo monitoring of mitochondrial fate at synapses during ageing and under neuroprotective conditions.
  2. Use optogenetic tools to stimulate synapse-restricted mitochondrial damage and, thereby, to detect mitophagy induction and its contribution to neurotransmission.
  3. Characterize the synaptic defects and assess behavioral deficits arising from mitophagy impairment.
  4. Conduct forward genetic screens for synaptic mitophagy modulators, towards augmenting mitochondrial quality control and resistance to age-related synaptic failure.

Expected Outcomes

The cumulative results of this proposal will decode the molecular mechanisms of neuronal mitophagy compartmentalization at synapses during ageing, providing critical insights with broad relevance to human health and quality of life.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.500.000
Totale projectbegroting€ 1.500.000

Tijdlijn

Startdatum1-1-2023
Einddatum31-12-2027
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINONpenvoerder

Land(en)

Greece

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Lysosomal exocytosis of metastable proteins to control synaptic function

The LEXSYN project aims to investigate lysosomal exocytosis in dendrites to understand its role in synaptic plasticity and neurodegeneration, utilizing advanced imaging and new monitoring tools.

€ 2.037.356
ERC Consolid...

Late life-applicable enhancement of longevity and fitness.

This project aims to identify molecular solutions to restore adaptive stress responses and promote healthy aging in late life using multi-omics and functional tests across various model organisms.

€ 2.000.000
ERC Advanced...

Synaptic resilience in Tau-induced neurodegeneration

This project aims to uncover the mechanisms of synaptic remodeling during hibernation to develop therapies that reverse Tau-induced synaptic decline in dementia.

€ 2.500.000
ERC Proof of...

The Mitochondrial Paradox: Embracing Mitohormesis for Improved Metabolic and Aging Health

This project aims to explore endothelial mitohormesis as a novel therapeutic approach to combat obesity and aging-related disorders using a specialized mouse model.

€ 150.000
ERC Starting...

Uncovering the molecular mechanisms of oligodendrocyte plasticity in cognitive aging.

This project aims to investigate oligodendrocyte plasticity and its role in cognitive decline with aging, using advanced techniques to identify therapeutic targets for brain rejuvenation.

€ 1.498.665